Respiratory symptoms require physiology-first assessment
Cough and congestion are common, but dyspnea may reflect asthma, COPD, pneumonia, pulmonary embolism, pneumothorax, heart failure, metabolic acidosis, anemia, acute coronary syndrome, or anxiety. A normal chest radiograph does not exclude every serious cause, and wheezing is not synonymous with asthma.
Begin by assessing whether the patient is ventilating and oxygenating safely, then localize the likely process.
Emergency red flags
Arrange EMS or emergency evaluation for:
- Severe respiratory distress, exhaustion, altered mental status, cyanosis, silent chest, or inability to speak normally
- Persistent hypoxemia, rapidly increasing oxygen need, or poor oximeter waveform with concerning appearance
- Stridor, drooling, tripod positioning, or threatened upper airway
- Sudden dyspnea with unilateral absent breath sounds or pneumothorax concern
- Pleuritic pain, hemoptysis, syncope, unilateral leg swelling, pregnancy/postpartum state, or pulmonary embolism concern
- Chest pressure, diaphoresis, nausea, or acute coronary syndrome pattern
- Severe asthma not responding promptly to bronchodilator therapy
- COPD exacerbation with somnolence, severe work of breathing, or hypercapnia concern
- Sepsis, hypotension, confusion, or severe pneumonia
- Angioedema or anaphylaxis
- Significant inhalational injury, carbon monoxide exposure, or toxic gas exposure
Pulse oximetry does not measure ventilation. A patient retaining carbon dioxide may have acceptable saturation while becoming somnolent.
Focused history
Clarify onset, progression, cough character, sputum, hemoptysis, dyspnea at rest or exertion, wheeze, stridor, pleuritic or pressure-like pain, orthopnea, paroxysmal nocturnal dyspnea, fever, sick contacts, and treatment response.
Review asthma/COPD diagnosis, prior intubation or ICU care, hospitalizations, baseline oxygen, home peak flow, rescue use, controller adherence, spacer technique, smoking/vaping, occupational exposure, allergens, and recent steroids or antibiotics.
Assess PE risk: prior VTE, active cancer, immobilization, surgery, estrogen exposure, pregnancy/postpartum state, unilateral leg symptoms, and hemoptysis. Ask about cardiac disease, renal disease, immune compromise, tuberculosis risk, and travel.
Examination
Record complete vitals, respiratory rate counted rather than estimated, oxygen saturation with waveform quality, work of breathing, speech, posture, mental status, and perfusion. Inspect for retractions, accessory muscle use, cyanosis, asymmetric chest movement, edema, and unilateral leg swelling.
Auscultate for aeration, wheeze, crackles, rhonchi, stridor, and asymmetry. Severe obstruction may produce little wheeze because airflow is minimal. Examine heart, neck veins, oropharynx, extremities, and skin when indicated.
Reassess after treatment and document objective changes in rate, saturation, aeration, speech, peak flow when used, and work of breathing.
Acute cough and bronchitis
Most acute bronchitis is viral. Cough can persist for several weeks after other symptoms improve. Purulent sputum does not prove bacterial infection. Antibiotics offer little benefit for uncomplicated acute bronchitis and create adverse effects, resistance, and C. difficile risk.
Look for pneumonia, asthma, pertussis, influenza, COVID-19, heart failure, and PE based on vitals and findings. Consider chest imaging when there is hypoxemia, tachypnea, focal findings, older age, significant comorbidity, or diagnostic uncertainty.
Avoid stacking sedating cough medications. Benzonatate must be kept away from children because accidental ingestion can be fatal. Counsel about drowsiness, driving, alcohol, and duplicate ingredients in combination products.
Asthma exacerbation
Assess severity through speech, respiratory rate, accessory muscles, oxygenation, aeration, mental status, peak flow when reliable, and response to bronchodilator. A history of prior intubation, recent systemic steroids, frequent rescue use, or poor controller adherence increases risk.
Use inhaled short-acting bronchodilator promptly, delivered by metered-dose inhaler with spacer or nebulizer based on severity and patient ability. Add ipratropium for severe exacerbations according to protocol. Systemic corticosteroids are appropriate for moderate-to-severe exacerbations or inadequate response, but review diabetes, infection, pregnancy, psychiatric effects, and recent cumulative exposure.
Modern asthma strategy recommends inhaled corticosteroid-containing treatment rather than reliance on short-acting bronchodilator alone for ongoing asthma care.[1] Discharge should address controller therapy, inhaler technique, trigger reduction, written action plan, and follow-up—not only a rescue refill.
Escalate for poor response, falling peak flow, persistent hypoxemia, fatigue, confusion, silent chest, or prior high-risk history.
COPD exacerbation
An exacerbation is worsening dyspnea, cough, or sputum beyond baseline. Consider pneumonia, heart failure, PE, pneumothorax, arrhythmia, and medication nonadherence.
Treat with short-acting bronchodilators, systemic corticosteroids when indicated, and oxygen targeted according to the patient’s baseline and hypercapnia risk. Antibiotics are selected for appropriate bacterial features and severity, not every exacerbation.
Somnolence, severe acidosis or hypercapnia concern, inability to manage secretions, hemodynamic instability, or failure of outpatient treatment requires hospital care. Verify inhaler technique and maintenance therapy at discharge using current GOLD guidance.[2]
Pneumonia
Pneumonia may cause fever, cough, dyspnea, pleuritic pain, focal crackles, tachypnea, or hypoxemia, but older and immune-compromised patients may present subtly. Chest imaging supports diagnosis and detects complications but early films can be nondiagnostic.
Assess severity, oxygenation, oral tolerance, comorbidities, pregnancy, resistant-pathogen risk, and follow-up. Use a validated severity framework as an aid, not a replacement for judgment. Antibiotic selection depends on age, comorbidities, allergies, recent antibiotics, local guidance, and whether atypical coverage is needed.
Clinical improvement should begin within the expected interval; worsening dyspnea, confusion, persistent fever, chest pain, or hypoxemia requires reassessment for resistant infection, effusion, empyema, sepsis, PE, or an alternate diagnosis.
Influenza, COVID-19, and RSV
Symptoms overlap and co-infection is possible. Test when results change treatment, infection control, or disposition. Higher-risk outpatients may benefit from time-sensitive antivirals. CDC guidance allows empiric influenza or COVID-19 treatment on clinical judgment without waiting for a positive test when risk and suspicion support it.[3]
Review COVID antiviral interactions and renal/hepatic function carefully. Influenza treatment is most beneficial early but remains indicated later for some high-risk or progressive cases. RSV treatment is mainly supportive in most outpatients; risk is higher at age extremes and with cardiopulmonary disease.
Pulmonary embolism
PE may present with dyspnea, pleuritic pain, tachycardia, hypoxemia, hemoptysis, syncope, or nonspecific symptoms. Normal oxygen saturation, chest radiograph, or absence of leg swelling does not exclude it.
Use validated pretest probability and rule-out pathways only in the populations for which they are intended. If PE cannot be safely excluded and definitive testing is unavailable, refer for emergency imaging. Do not treat unexplained tachycardia as anxiety before considering PE and other physiologic causes.
Pneumothorax and pleural disease
Sudden unilateral pleuritic pain and dyspnea with asymmetric breath sounds suggests pneumothorax. Tension physiology—hypotension, severe distress, distended neck veins, tracheal deviation as a late sign—requires immediate decompression by trained clinicians and EMS transfer.
Pleural effusion or empyema may cause dyspnea, fever, pleuritic pain, dullness, and reduced breath sounds. Ultrasound can identify pleural fluid in trained hands, but hospital evaluation is often required for drainage and source control.
Upper-airway and inhalational problems
Stridor localizes obstruction to the upper airway and is not wheeze. Epiglottitis, anaphylaxis, foreign body, croup, deep-neck infection, and angioedema require airway-focused assessment. Avoid agitating a child with suspected critical obstruction.
Carbon monoxide poisoning can cause headache, dizziness, nausea, chest pain, confusion, and multiple sick household members. Standard pulse oximetry may appear normal. Remove from exposure, administer oxygen according to protocol, contact emergency services or Poison Control, and obtain co-oximetry.
Testing
- Pulse oximetry: Confirm waveform and trend.
- Peak flow: Helpful in cooperative asthma patients; do not delay treatment.
- Chest radiography: Evaluates pneumonia, pneumothorax, edema, and some complications but does not exclude PE or early disease.
- ECG: Important with chest symptoms, tachycardia, older age, or cardiopulmonary risk.
- Respiratory testing: Use when treatment or infection control changes.
- Capnography or blood gas: Hospital-level assessment when ventilation is in question.
Medication and device safeguards
Demonstrate inhaler and spacer technique. Confirm the patient knows controller versus rescue medication. Excess beta-agonist can cause tremor, tachycardia, hypokalemia, and lactic acidosis; persistent symptoms should not be managed by unlimited rescue dosing.
Systemic steroids require an indication and cumulative-exposure awareness. Antibiotics require a bacterial syndrome. Oxygen is a drug: document indication, delivery, target, and response.
Disposition and follow-up
Outpatient care requires stable physiology, acceptable work of breathing, sustained response to therapy, medication access, competent device use, and reliable follow-up. Provide emergency precautions for increased breathing effort, blue color, confusion, inability to speak, chest pain, syncope, hemoptysis, declining peak flow, or rescue medication that does not last.
Documentation and coding
Document onset, risk factors, baseline lung status, complete vitals, respiratory effort, speech, aeration, oximetry quality, pre/post treatment findings, tests, medication response, device teaching, and disposition reasoning.
Common codes include R05.9 cough, R06.02 shortness of breath, R06.2 wheezing, J20.9 acute bronchitis, J18.9 pneumonia, J45.901 unspecified asthma with exacerbation, and J44.1 COPD with exacerbation. Verify specificity and current CPT rules for nebulizer treatment, spirometry, imaging, testing, and medication administration.
Clinical pearls
- Count respiratory rate; do not estimate it.
- Oxygen saturation is not ventilation.
- A silent chest can indicate life-threatening obstruction.
- Purulent sputum does not prove bacterial bronchitis.
- Wheeze is not always asthma.
- A normal chest radiograph does not exclude PE.
- Treat the asthma exacerbation and repair the long-term asthma plan.
- Inhaler technique is a clinical intervention.
- Stridor is an airway problem.
- Carbon monoxide poisoning can have normal standard pulse oximetry.
- Reassess after every significant respiratory treatment.
Conclusion
Respiratory urgent care begins with physiology: work of breathing, mentation, oxygenation, ventilation, and treatment response. Only then should the clinician settle on bronchitis, asthma, COPD, pneumonia, or another label. When respiratory reserve is failing or PE, pneumothorax, airway obstruction, sepsis, or toxic exposure is possible, rapid escalation protects life.
References
- Global Initiative for Asthma. Global strategy for asthma management and prevention, 2025 [Internet]. Available from: https://ginasthma.org/2025-gina-strategy-report/
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2026 report [Internet]. Available from: https://goldcopd.org/2026-gold-report-and-pocket-guide/
- Centers for Disease Control and Prevention. Clinical guidance for outpatients with acute respiratory illness at higher risk of severe COVID-19 and/or influenza [Internet]. Atlanta: CDC; 2025 Dec 19 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/flu/hcp/clinical-guidance/testing-guidance-for-outpatient.html